HighTower Advisors »

Cortexyme shares owned by HighTower Advisors

Quarter-by-quarter ownership of Cortexyme (QNCX) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Cortexyme

Tip: Access up to 7 years of quarterly data

All positions including Cortexyme held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cortexyme by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $251k 342k 0.73

More positions owned by HighTower Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Exxon Mobil Corporation (XOM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Johnson & Johnson (JNJ)

View all positions for HighTower Advisors

Top funds holding Cortexyme

Tang Capital Management
Vanguard Group
EPIQ Capital Group
Renaissance Technologies
BlackRock
HighTower Advisors
Geode Capital Management
Alphabet
Bank of America Corporation
Bridgeway Capital Management
Susquehanna International
Citadel Advisors
Two Sigma Advisers
Mariner Wealth Advisors
State Street Corporation

View all funds holding Cortexyme